INTRODUCTION: Besides standard evaluation of histology, immunology and molecular markers as MGNT, IDH etc. an additional screening for biomarkers, genetic alterations and epigenetic features deriving from tissue from primary or recurrent brain tumors may harbor potential as prognostic and predictive information. With this pilot study we intended to examine in how far tissue obtained by stereotactic biopsy can be utilized for extended evaluation. METHODS: Stereotactically guided serial tissue samples (1mm diameter) from 16 patients were analyzed. Besides clinically obligatory routine histo-pathological, immunological and molecular evaluation (e.g. GFAP, S100, Vimentin, MAP2, EGFR, IDH1, p53 and MIB-1) probes were also utilized for analysis for further immunohistochemistry, for genomic DNA extraction, for RNA and protein extraction: The biochemical analysis was done by Western blot using various antibodies (e.g. ALDH1, AHR, GFAP, beta-actin). Furthermore, molecular techniques were applied including the methylation status of the MGMT promoter by bi-sulfit conversion of the DNA and following PCR and the IDH1/2 mutation status verification by pyro-sequencing. RESULTS: In most of the 16 patients the clinical routine diagnostic could be evaluated including MGMT promotor- and IDH1/2 mutation status (two diffuse astrocytomas, two anaplastic astrocytomas, nine glioblastomas, three other tumors). Genomic DNA could be extracted from stereotactic probes. RNA extraction was also possible, but the amount of cDNA obtained from the RNA from stereotactic samples was significant lower in 14/16 patient samples than the amount of cDNA normally used for quantitative RT-PCR from open resection. Besides, there was no biopsy-related morbidity. CONCLUSION: Tissue provided by stereotactically guided serial biopsies in patients with primary and recurrent brain tumors is safe and feasible. Besides clinical routine diagnostic the tissue can also sufficiently be used for of a variety of additional immunohistochemical, biochemical, and molecular analyses. This information may provide valuable and potential treatment relevant factors.